VEGFA and cancer: Immunotherapeutic approaches for advanced GC, widely employed among others, include ICIs, adoptive cell therapy, antibodies targeting vascular endothelial growth factor A (VEGFA), cancer vaccines, and chimeric antigen receptor (CAR) T-cell therapy [9,10,11,12].